APA

Ding X., Chaiteerakij R., Moser C. D., Shaleh H., Boakye J., Chen G., Ndzengue A., Li Y., Zhou Y., Huang S., Sinicrope F. A., Zou X., Thomas M. B., Smith C. D. & Roberts L. R. (20180117). Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells. : Oncotarget.

Chicago

Ding Xiwei, Chaiteerakij Roongruedee, Moser Catherine D, Shaleh Hassan, Boakye Jeffrey, Chen Gang, Ndzengue Albert, Li Ying, Zhou Yanling, Huang Shengbing, Sinicrope Frank A, Zou Xiaoping, Thomas Melanie B, Smith Charles D and Roberts Lewis R. 20180117. Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells. : Oncotarget.

Harvard

Ding X., Chaiteerakij R., Moser C. D., Shaleh H., Boakye J., Chen G., Ndzengue A., Li Y., Zhou Y., Huang S., Sinicrope F. A., Zou X., Thomas M. B., Smith C. D. and Roberts L. R. (20180117). Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells. : Oncotarget.

MLA

Ding Xiwei, Chaiteerakij Roongruedee, Moser Catherine D, Shaleh Hassan, Boakye Jeffrey, Chen Gang, Ndzengue Albert, Li Ying, Zhou Yanling, Huang Shengbing, Sinicrope Frank A, Zou Xiaoping, Thomas Melanie B, Smith Charles D and Roberts Lewis R. Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells. : Oncotarget. 20180117.